Cardiol Therapeutics Inc <CRDL.O>: B. Riley initiates coverage with buy rating; target price $11
CRDL•Related News
Cohen & Steers holds 2.92% stake in Prologis, Takeover Panel filing shows
PLD•
Kraft Heinz to switch listing to NYSE
KHC•
Kodiak AI partners with AMD to use EPYC processors in seventh-generation autonomous truck platform
KDK•
Box Inc <BOX.N>: UBS Raises Target Price to $37 From $29
BOX•
Oil firms fall as Iran-Oman talks revive hopes of Hormuz reopening
XLE•